ioversol - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
OPTIRAY 240 Ioversol 63.63 g/125 mL injection syringe (power injector)
AUST R: 46640
Active ingredients:
ioversol

Dosage form:
Injection, solution

Sponsor:
Guerbet Australia Pty Ltd

Phone:
0280753007

Deletion from market:
29 Jan 2025

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

Management action:
OPTIRAY 240 Ioversol 63.63 g/125 mL injection syringe (power injector) (AUST R: 46640) has been in long term shortage since 2022. The sponsor has made the commercial decision to discontinue this product. For further information, contact Guerbet Australia Pty Ltd on 02 8075 3007.

OPTIRAY 320 Ioversol 33.9 g/50 mL injection syringe (hand held and power injector)
AUST R: 46641
Active ingredients:
ioversol

Dosage form:
Injection, solution

Sponsor:
Guerbet Australia Pty Ltd

Phone:
0280753007

Deletion from market:
29 Jan 2025

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Manufacturing

Management action:
OPTIRAY 320 Ioversol 33.9 g/50 mL injection syringe (hand held and power injector) (AUST R: 46641) has been in long term shortage since 2022. The sponsor has made the commercial decision to discontinue this product. For further information, contact Guerbet Australia Pty Ltd on 02 8075 3007.

OPTIRAY 320 Ioversol 33.9g/50mL injection vial
AUST R: 49422
Active ingredients:
ioversol

Dosage form:
Injection, solution

Sponsor:
Guerbet Australia Pty Ltd

Phone:
02 8075 3007

Deletion from market:
29 Jan 2025

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Manufacturing

Management action:
OPTIRAY 320 Ioversol 33.9g/50mL injection vial (AUST R: 49422) has been in long term shortage since 2022. The sponsor has made the commercial decision to discontinue this product. For further information, contact Guerbet Australia Pty Ltd on 02 8075 3007.

OPTIRAY 320 Ioversol 84.75 g/125 mL injection syringe (power injector)
AUST R: 46642
Active ingredients:
ioversol

Dosage form:
Injection, solution

Sponsor:
Guerbet Australia Pty Ltd

Phone:
0280753007

Deletion from market:
29 Jan 2025

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Unexpected increase in demand due to other sponsors unable to supply

Management action:
OPTIRAY 320 Ioversol 84.75 g/125 mL injection syringe (power injector) (AUST R: 46642) has been in long term shortage since 2022. The sponsor has made the commercial decision to discontinue this product. For further information, contact Guerbet Australia Pty Ltd on 02 8075 3007.

OPTIRAY 320 ULTRAJECT ioversol 50.8g/75mL injection syringe
AUST R: 73580
Active ingredients:
ioversol

Dosage form:
Injection, solution

Sponsor:
Guerbet Australia Pty Ltd

Phone:
0280753007

Deletion from market:
29 Jan 2025

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Manufacturing

Management action:
OPTIRAY 320 ULTRAJECT ioversol 50.8g/75mL injection syringe (AUST R: 73580) has been in long term shortage since 2022. The sponsor has made the commercial decision to discontinue this product. For further information, contact Guerbet Australia Pty Ltd on 02 8075 3007.

OPTIRAY 350 Ioversol 74% w/v 148.2g/200mL injection vial
AUST R: 49612
Active ingredients:
ioversol

Dosage form:
Injection, solution

Sponsor:
Guerbet Australia Pty Ltd

Phone:
02 8075 3007

Deletion from market:
29 Jan 2025

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Manufacturing

Management action:
OPTIRAY 350 Ioversol 74% w/v 148.2g/200mL injection vial (AUST R: 49612) has been in long term shortage since 2022. The sponsor has made the commercial decision to discontinue this product. For further information, contact Guerbet Australia Pty Ltd on 02 8075 3007.

OPTIRAY 350 Ioversol 74% w/v 55.575g/75mL injection vial
AUST R: 47997
Active ingredients:
ioversol

Dosage form:
Injection, solution

Sponsor:
Guerbet Australia Pty Ltd

Phone:
02 8075 3007

Deletion from market:
29 Jan 2025

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Manufacturing

Management action:
OPTIRAY 350 Ioversol 74% w/v 55.575g/75mL injection vial (AUST R: 47997) has been in long term shortage since 2022. The sponsor has made the commercial decision to discontinue this product. For further information, contact Guerbet Australia Pty Ltd on 02 8075 3007.

OPTIRAY 350 ULTRAJECT Ioversol 74% w/v 37.05g/50mL injection syringe
AUST R: 51796
Active ingredients:
ioversol

Dosage form:
Injection, solution

Sponsor:
Guerbet Australia Pty Ltd

Phone:
0280753007

Deletion from market:
28 Jan 2025

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Manufacturing

Management action:
OPTIRAY 350 ULTRAJECT Ioversol 74% w/v 37.05g/50mL injection syringe (AUST R: 51796) has been in long term shortage since 2022. The sponsor has made the commercial decision to discontinue this product. For further information, contact Guerbet Australia Pty Ltd on 02 8075 3007.